Jian Feng
机构:Affiliated Hospital of Southwest Medical University · ORCID:0000-0003-4853-6413
发表论文 71 篇 · 总被引 2190 次 · h-index 24
代表论文
- Insights into SGLT2 inhibitor treatment of diabetic cardiomyopathy: focus on the mechanisms (2023 · Cardiovascular Diabetology · 被引 117)
- Pyroptosis-Related Inflammasome Pathway: A New Therapeutic Target for Diabetic Cardiomyopathy (2022 · Frontiers in Pharmacology · 被引 68)
- Naringenin: A Promising Therapeutic Agent against Organ Fibrosis (2021 · Oxidative Medicine and Cellular Longevity · 被引 68)
- Naringenin ameliorates myocardial injury in STZ-induced diabetic mice by reducing oxidative stress, inflammation and apoptosis via regulating the Nrf2 and NF-κB signaling pathways (2022 · Frontiers in Cardiovascular Medicine · 被引 43)
- Oxidative stress signaling in the pathogenesis of diabetic cardiomyopathy and the potential therapeutic role of antioxidant naringenin (2023 · Redox Report · 被引 40)
- Targeting gut microbiota in aging-related cardiovascular dysfunction: focus on the mechanisms (2023 · Gut Microbes · 被引 27)